AUSTIN, Texas , July 11, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 . A press release announcing the results is scheduled for release after the close of trading on

AUSTIN, Texas , July 1, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced that the company submitted the ARIES® MRSA Assay to the U.S. Food and Drug Administration ( FDA ) for clearance on Friday, June 28, 2019 . The assay is a real-time, quantitative polymerase chain reaction